← Leaderboards
Ute H Hochgeschwender
Oklahoma Medical Research Foundation
$6,447,258
Attributed
$12,101,530
Total exposure
18
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,101,530 · 18
By mechanism
R01$5,428,102 · 2
R21$3,645,575 · 8
U01$2,371,744 · 1
P20$503,424 · 6
R03$152,685 · 1
Top collaborators
- Christopher Irwin Moore12 shared
- Nathan Christopher Shaner7 shared
- Julien Rossignol6 shared
- Luis De Lecea4 shared
- Hong-Yuan Chu2 shared
- Diane Lipscombe2 shared
- Ajit Sharma2 shared
- Assaf A Gilad1 shared
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- Judith A James$55,525,870
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsBrainOptogeneticsBehaviorCellsNeural CircuitLightLuciferasesIn VivoOpsinPeripheralResearch PersonnelLuciferinBehavioralMental DisordersComplexNew TechnologyAnimalsNervous System DisorderNeurosciencesMissionLight EmissionNeuroregulationTechnology
Grant awards (42)
Functional circuit dissection of the Hcrt system$161,303
R21 · FY2025 · MH · contact PI
Functional circuit dissection of the Hcrt system$81,373
R21 · FY2025 · MH · contact PI
Functional circuit dissection of the Hcrt system$238,166
R21 · FY2024 · MH · contact PI
Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis$174,595
R21 · FY2024 · NS · contact PI
Functional circuit dissection of the Hcrt system - Diversity Supplement Kennedy$26,684
R21 · FY2024 · MH · contact PI
Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis$2,416
R21 · FY2024 · NS · contact PI
Targeted Cortical Circuit Manipulation in Parkinson's Disease$265,113
R21 · FY2023 · NS
Targeted Cortical Circuit Manipulation in Parkinson's Disease$220,075
R21 · FY2023 · NS
Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis$210,785
R21 · FY2023 · NS · contact PI
Selective Control of Synaptically-Connected Circuit Elements by Interluminescence - Diversity Supplement SILVAGNOLI$79,812
R01 · FY2023 · NS · contact PI
Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis$15,009
R21 · FY2023 · NS · contact PI
Selective Control of Synaptically-Connected Circuit Elements by Interluminescence$3,208,469
R01 · FY2021 · NS · contact PI
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function$2,026,634
R01 · FY2021 · EB · contact PI
Selective Control of Synaptically-Connected Circuit Elements by Interluminescence - Diversity Supplement: E. CRESPO$113,187
R01 · FY2021 · NS · contact PI
Non-Invasive Nanoparticle Platform for Tool Delivery to the Brain$433,500
R21 · FY2019 · EY
Non-Invasive Nanoparticle Platform for Tool Delivery to the Brain$86,824
R21 · FY2019 · EY
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$747,421
U01 · FY2018 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$93,289
U01 · FY2018 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$728,657
U01 · FY2017 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$17,957
U01 · FY2017 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$11,310
U01 · FY2017 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$11,310
U01 · FY2017 · NS · contact PI
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation$761,800
U01 · FY2016 · NS · contact PI
Employing subcellular calcium to control membrane voltage$230,250
R21 · FY2016 · EY · contact PI
Employing subcellular calcium to control membrane voltage$241,375
R21 · FY2015 · EY · contact PI
Genetically Encoded Light-Production and Light-Sensing for Neuronal Manipulation$17,575
R21 · FY2015 · MH · contact PI
Genetically Encoded Light-Production and Light-Sensing for Neuronal Manipulation$173,334
R21 · FY2014 · MH · contact PI
Genetically Encoded Light-Production and Light-Sensing for Neuronal Manipulation$7,922
R21 · FY2014 · MH · contact PI
Genetically Encoded Light-Production and Light-Sensing for Neuronal Manipulation$235,500
R21 · FY2013 · MH · contact PI
A transgenic platform for highly specific and remote control of neuronal activity$229,846
R21 · FY2012 · MH · contact PI
A transgenic platform for highly specific and remote control of neuronal activity$207,680
R21 · FY2011 · MH · contact PI
CORE: MICROINJECTION CORE FACILITY$70,638
P20 · FY2008 · RR · contact PI
CORE: MICROINJECTION CORE FACILITY$72,090
P20 · FY2007 · RR · contact PI
Deriving ES Cell Lines from a Down Syndrome Mouse Model$75,435
R03 · FY2006 · HD · contact PI
CORE: MICROINJECTION CORE FACILITY$74,263
P20 · FY2006 · RR · contact PI
A Mouse Model of the Human 18q Deletion Syndrome$193,125
R21 · FY2005 · RR
COBRE: OMRF: MICROINJECTION CORE FACILITY: STEM CELLS$77,558
P20 · FY2005 · RR
Deriving ES Cell Lines from a Down Syndrome Mouse Model$77,250
R03 · FY2005 · HD
COBRE: CORE5: MICROINJECTION CORE FACILITY$58,950
P20 · FY2005 · RR
A Mouse Model of the Human 18q Deletion Syndrome$193,125
R21 · FY2004 · RR
COBRE: CORE5: MICROINJECTION CORE FACILITY$80,870
P20 · FY2004 · RR
COBRE: OMRF: MICROINJECTION CORE FACILITY: STEM CELLS$69,055
P20 · FY2004 · RR